DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

10,300

Employees10,300

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

10,300

Employees10,300

DXCM Key Statistics

Market cap

26.70B

Market cap26.70B

Price-Earnings ratio

47.66

Price-Earnings ratio47.66

Dividend yield

—

Dividend yield—

Average volume

5.30M

Average volume5.30M

High today

$69.00

High today$69.00

Low today

$67.24

Low today$67.24

Open price

$67.75

Open price$67.75

Volume

3.35M

Volume3.35M

52 Week high

$93.25

52 Week high$93.25

52 Week low

$57.52

52 Week low$57.52

DXCM News

TipRanks 3d

DexCom price target lowered to $85 from $105 at Citi

Citi lowered the firm’s price target on DexCom (DXCM) to $85 from $105 and keeps a Buy rating on the shares. The firm is cautious on medical technology entering...

Simply Wall St 7d

How Investors May Respond To DexCom G7 Safety Scrutiny and Expert Endorsements

In September 2025, DexCom faced scrutiny after reports alleged unauthorized design changes and safety risks linked to its G7 continuous glucose monitoring syste...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.